BGT vs DOC

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

54MEDIUM

DOC

DOCTORCARE CDI 1:1 [DOC]

54MEDIUM

Score Breakdown

BGT DOC
Technical
68
43
Catalyst
51
53
Sentiment
50
50
Fundamental
41
88
Momentum
80
71
Risk Gate
34
50

Key Metrics

BGT Metric DOC
$10.7MMarket Cap$49.5M
128KAvg Volume (20d)188K
N/AShort InterestN/A
$0.06152-Week High$0.210
$0.01652-Week Low$0.080
+0.0%Daily Change+7.4%
$0.035Entry Price$0.145
-202.2%ROE+617.6%
N/AProfit Margin+3.0%

Active Signals

BGT Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.7 quarters)
●Strong revenue growth (+208%)
●Micro-cap ($5-20M) - high risk
●CANSLIM S: Tight float (35%)
●Not enough chatter to gauge sentiment — defaulting to neutral

DOC Signals

●Volume surging at 4.0x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Lagging the Small Ords index — relative strength of 0.88, underperforming its peers
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●4C filed 2026-01-28
●Low P/S ratio (1.3x)
●Moderate revenue growth (+7%)

Ask Scout AI to compare BGT and DOC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BGT Full Analysis → DOC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).